| Emily Rivers, LMSW, CACP | |
|
1068 S Lake Dr, Lexington, SC 29073-3720 | |
| (803) 726-9424 | |
| Not Available |
| Full Name | Emily Rivers |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1068 S Lake Dr, Lexington, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215288725 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 9784 (South Carolina) | Primary |
| Entity Name | The Nurturing Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831543891 PECOS PAC ID: 1850642943 Enrollment ID: O20181001000000 |
News Archive
City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor. Karen S. Aboody, M.D., associate professor in City of Hope's Department of Neurosciences, leads the research team that developed this treatment strategy. Jana Portnow, M.D., assistant professor and assistant director of the Brain Tumor Program at City of Hope, is the principal investigator for the clinical trial.
A study led by Mayo Clinic suggests remission from Crohn's disease may be more likely if patients get biologic therapy combined with immune-suppressing drugs first instead of immune-suppressing drugs alone. The study, published in the April 15, 2010 issue of the New England Journal of Medicine, found treatment of moderate to severe Crohn's disease with infliximab plus azathioprine allows more patients to achieve remission and mucosal healing than therapy with azathioprine alone.
"Humanitarian agencies are trying to keep up with the rising needs stemming from the ongoing conflict in Syria, the top United Nations relief official said Tuesday, while noting that limited access is preventing everyone who requires assistance from receiving it," the U.N. News Centre reports.
A study led by researchers at the University of Toronto, Canada, has found evidence that immunoglobulin G (IgG) antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are sustained for at least three months.
Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority populations.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Rivers, LMSW, CACP 448 Colony Lakes Dr, Lexington, SC 29073-6702 Ph: (803) 920-6518 | Emily Rivers, LMSW, CACP 1068 S Lake Dr, Lexington, SC 29073-3720 Ph: (803) 726-9424 |
News Archive
City of Hope researchers received approval from the U.S. Food and Drug Administration (FDA) to conduct the first-in-human study of a neural stem cell-based therapy targeting recurrent high-grade gliomas, the most aggressive type of brain tumor. Karen S. Aboody, M.D., associate professor in City of Hope's Department of Neurosciences, leads the research team that developed this treatment strategy. Jana Portnow, M.D., assistant professor and assistant director of the Brain Tumor Program at City of Hope, is the principal investigator for the clinical trial.
A study led by Mayo Clinic suggests remission from Crohn's disease may be more likely if patients get biologic therapy combined with immune-suppressing drugs first instead of immune-suppressing drugs alone. The study, published in the April 15, 2010 issue of the New England Journal of Medicine, found treatment of moderate to severe Crohn's disease with infliximab plus azathioprine allows more patients to achieve remission and mucosal healing than therapy with azathioprine alone.
"Humanitarian agencies are trying to keep up with the rising needs stemming from the ongoing conflict in Syria, the top United Nations relief official said Tuesday, while noting that limited access is preventing everyone who requires assistance from receiving it," the U.N. News Centre reports.
A study led by researchers at the University of Toronto, Canada, has found evidence that immunoglobulin G (IgG) antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are sustained for at least three months.
Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority populations.
› Verified 9 days ago
Bonnie Watts Mooney, LISW-CP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 301a Palmetto Park Blvd, Lexington, SC 29072 Phone: 803-359-3545 Fax: 803-359-2111 | |
Emma Simone Rava, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 205 Hickory Hill Rd, Lexington, SC 29072 Phone: 703-999-2500 | |
Lisa Amodio, LISW-CP, LCSW-R Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 461 Walking Ln, Lexington, SC 29073 Phone: 315-416-3799 | |
Mrs. Jennifer Elizabeth Keschinger, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1316 N Lake Dr, Adolescent Recovery Center, Lexington, SC 29072 Phone: 803-951-1902 | |
Ms. Catherine Elyse Sayles, LISW-CP Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 105 Point Dr, Lexington, SC 29072 Phone: 803-466-9571 | |
Elizabeth V Freeman, LISW, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 224 E Main St, Lexington, SC 29072 Phone: 803-808-5222 Fax: 803-957-2062 | |
Mrs. June E. Beasley-keefe, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 605 W Main St, Lexington, SC 29072 Phone: 803-359-5526 |